In8bio
Price & Volume
Stats
See moreOpen | $2.12 |
Previous Close | $2.11 |
Day Range | $2.10-$2.16 |
52W Range | $1.91-$16.71 |
Market Cap | $9M |
Shares Short | 45,893 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$9.16 |
News
See moreYahoo Finance • 2 months ago
IN8bio GAAP EPS of -$1.24 beats by $0.56
Yahoo Finance • 3 months ago
IN8bio Recognizes Achievement of 4-Years in Remission for Patient Treated with INB-200 in Glioblastoma Trial
Yahoo Finance • 4 months ago
IN8bio Presents Positive Phase 1 Data of INB-200 in Newly Diagnosed GBM Demonstrating Prolonged Progression-Free Survival
Yahoo Finance • 6 months ago
IN8bio to Participate at the 11th Annual Immuno-Oncology 360° Conference 2025
About
CEO | Mr. Tai-Wei Ho |
CFO | Mr. Patrick McCall CPA |
Address | 350 5th Avenue, New York, NY, United States, 10118 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 18 |
